Vinik E - Search Results

1

Measuring the relationship of quality of life and health status, including tumor burden, symptoms, and biochemical measures in patients with neuroendocrine tumors.

Vinik E, Silva MP, Vinik AI. Vinik E, et al. Among authors: vinik ai. Endocrinol Metab Clin North Am. 2011 Mar;40(1):97-109, viii. doi: 10.1016/j.ecl.2010.12.008. Endocrinol Metab Clin North Am. 2011. PMID: 21349413 Review.

2

Prevention of the complications of diabetes.

Vinik AI, Vinik E. Vinik AI, et al. Among authors: vinik e. Am J Manag Care. 2003 Mar;9(3 Suppl):S63-80; quiz S81-4. Am J Manag Care. 2003. PMID: 12653455 Free article. Review.

3

The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy.

Vinik EJ, Hayes RP, Oglesby A, Bastyr E, Barlow P, Ford-Molvik SL, Vinik AI. Vinik EJ, et al. Among authors: vinik ai. Diabetes Technol Ther. 2005 Jun;7(3):497-508. doi: 10.1089/dia.2005.7.497. Diabetes Technol Ther. 2005. PMID: 15929681

4

Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumors.

Woltering EA, Mamikunian PM, Zietz S, Krutzik SR, Go VL, Vinik AI, Vinik E, O'Dorisio TM, Mamikunian G. Woltering EA, et al. Among authors: vinik e, vinik ai. Pancreas. 2005 Nov;31(4):392-400. doi: 10.1097/01.mpa.0000186249.89081.0d. Pancreas. 2005. PMID: 16258376

5

Validation of serum versus plasma measurements of chromogranin a levels in patients with carcinoid tumors: lack of correlation between absolute chromogranin a levels and symptom frequency.

Woltering EA, Hilton RS, Zolfoghary CM, Thomson J, Zietz S, Go VL, Vinik AI, Vinik E, O'Dorisio TM, Mamikunian G. Woltering EA, et al. Among authors: vinik e, vinik ai. Pancreas. 2006 Oct;33(3):250-4. doi: 10.1097/01.mpa.0000235302.73615.d4. Pancreas. 2006. PMID: 17003646

6

Development of the Norfolk quality of life tool for assessing patients with neuroendocrine tumors.

Vinik E, Carlton CA, Silva MP, Vinik AI. Vinik E, et al. Among authors: vinik ai. Pancreas. 2009 Apr;38(3):e87-95. doi: 10.1097/MPA.0b013e31819b6441. Pancreas. 2009. PMID: 19276865

7

German-translated Norfolk quality of life (QOL-DN) identifies the same factors as the English version of the tool and discriminates different levels of neuropathy severity.

Vinik EJ, Paulson JF, Ford-Molvik SL, Vinik AI. Vinik EJ, et al. J Diabetes Sci Technol. 2008 Nov;2(6):1075-86. doi: 10.1177/193229680800200616. J Diabetes Sci Technol. 2008. PMID: 19885296 Free PMC article.

8

Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate.

Boyd A, Casselini C, Vinik E, Vinik A. Boyd A, et al. Among authors: vinik a, vinik e. J Diabetes Sci Technol. 2011 May 1;5(3):714-22. doi: 10.1177/193229681100500326. J Diabetes Sci Technol. 2011. PMID: 21722587 Free PMC article. Clinical Trial.

9

Norfolk QOL-DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy.

Vinik EJ, Vinik AI, Paulson JF, Merkies IS, Packman J, Grogan DR, Coelho T. Vinik EJ, et al. J Peripher Nerv Syst. 2014 Jun;19(2):104-14. doi: 10.1111/jns5.12059. J Peripher Nerv Syst. 2014. PMID: 24738700

10

Falls risk in older adults with type 2 diabetes.

Vinik AI, Vinik EJ, Colberg SR, Morrison S. Vinik AI, et al. Clin Geriatr Med. 2015 Feb;31(1):89-99, viii. doi: 10.1016/j.cger.2014.09.002. Epub 2014 Nov 15. Clin Geriatr Med. 2015. PMID: 25453303 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page